Table 2 Treatment characteristics
N = 44 | % | |
|---|---|---|
IORT indication | ||
Pelvic recurrence | 22 | 50% |
Retroperitoneal recurrence | 22 | 50% |
Resection | ||
R0 | 36 | 88% |
R1 | 08 | 12% |
IORT device | ||
Electron (IOERT) | 43 | 97% |
HDR | 01 | 3% |
IOERT dose | ||
Median (first-line EBRT) | 15 Gy (range:10–21 Gy) | |
Median (no first-line EBRT) | 12 Gy (range: 9–15 Gy) | |
IOERT energy | ||
Median | 9 MeV (range: 6–15 MeV) | |
Association with adjuvant ebrt | ||
Yes | 17 | 38.6% |
No | 27 | 61.4% |
Association with chemotherapy | ||
Yes | 11 | 25% |
No | 33 | 75% |